Literature DB >> 17096167

Raver1 is an integral component of muscle contractile elements.

Anke Zieseniss1, Ulrich Schroeder, Sabine Buchmeier, Cora-Ann Schoenenberger, Joop van den Heuvel, Brigitte M Jockusch, Susanne Illenberger.   

Abstract

Raver1, a ubiquitously expressed protein, was originally identified as a ligand for metavinculin, the muscle-specific isoform of the microfilament-associated protein vinculin. The protein resides primarily in the nucleus, where it colocalises and may interact with polypyrimidine-tract-binding protein, which is involved in alternative splicing processes. During skeletal muscle differentiation, raver1 translocates to the cytoplasm and eventually targets the Z-line of sarcomeres. Here, it colocalises with metavinculin, vinculin and alpha-actinin, all of which have biochemically been identified as raver1 ligands. To obtain more information about the potential role of raver1 in muscle structure and function, we have investigated its distribution and fine localisation in mouse striated and smooth muscle, by using three monoclonal antibodies that recognise epitopes in different regions of the raver1 protein. Our immunofluorescence and immunoelectron-microscopic results indicate that the cytoplasmic accumulation of raver1 is not confined to skeletal muscle but also occurs in heart and smooth muscle. Unlike vinculin and metavinculin, cytoplasmic raver1 is not restricted to costameres but additionally represents an integral part of the sarcomere. In isolated myofibrils and in ultrathin sections of skeletal muscle, raver1 has been found concentrated at the I-Z-I band. A minor fraction of raver1 is present in the nuclei of all three types of muscle. These data indicate that, during muscle differentiation, raver1 might link gene expression with structural functions of the contractile machinery of muscle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17096167     DOI: 10.1007/s00441-006-0322-1

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  7 in total

1.  Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury.

Authors:  Marion Hölscher; Monique Silter; Sabine Krull; Melanie von Ahlen; Amke Hesse; Peter Schwartz; Ben Wielockx; Georg Breier; Dörthe M Katschinski; Anke Zieseniss
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

2.  Desmoplakin and talin2 are novel mRNA targets of fragile X-related protein-1 in cardiac muscle.

Authors:  Samantha A Whitman; Cathleen Cover; Lily Yu; David L Nelson; Daniela C Zarnescu; Carol C Gregorio
Journal:  Circ Res       Date:  2011-06-09       Impact factor: 17.367

3.  A role for polypyrimidine tract binding protein in the establishment of focal adhesions.

Authors:  Ivan Babic; Shalini Sharma; Douglas L Black
Journal:  Mol Cell Biol       Date:  2009-08-10       Impact factor: 4.272

4.  A helix replacement mechanism directs metavinculin functions.

Authors:  Erumbi S Rangarajan; Jun Hyuck Lee; S D Yogesha; Tina Izard
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

5.  Raver1 interactions with vinculin and RNA suggest a feed-forward pathway in directing mRNA to focal adhesions.

Authors:  Jun Hyuck Lee; Erumbi S Rangarajan; S D Yogesha; Tina Izard
Journal:  Structure       Date:  2009-06-10       Impact factor: 5.006

6.  Transcriptome analysis of spermatogenically regressed, recrudescent and active phase testis of seasonally breeding wall lizards Hemidactylus flaviviridis.

Authors:  Mukesh Gautam; Amitabh Mathur; Meraj Alam Khan; Subeer S Majumdar; Umesh Rai
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

Review 7.  New insights into functional roles of the polypyrimidine tract-binding protein.

Authors:  Maria Grazia Romanelli; Erica Diani; Patricia Marie-Jeanne Lievens
Journal:  Int J Mol Sci       Date:  2013-11-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.